AnaptysBio, Inc.

Filed a patent for "btla agonist for modulation of dendritic cells" on Thu, May 25, 2023

Filed a patent for "antibodies directed against interleukin-33 (il-33)" on Thu, September 5, 2024

Filed a patent for "cd122 binding agents and method of using same" on Mon, November 7, 2022

Filed a patent for "antibody agents directed against lymphocyte activation gene-3 (lag-3) and uses thereof" on Thu, May 16, 2024

Filed a patent for "anti-interleukin 36 receptor (il-36r) therapy for ichthyosis" on Thu, August 31, 2023

Filed a patent for "b and t lymphocyte attenuator (btla) modulators and method of using same" on Thu, December 7, 2023

Filed a patent for "antibodies directed against programmed death-1(pd-1)" on Thu, October 19, 2023

Filed a patent for "anti-interleukin 36 receptor (il-36r) therapy for hidradenitis suppurativa" on Thu, March 14, 2024

Filed a patent for "antibody composition" on Fri, November 10, 2023

Filed a patent for "b and t lymphocyte attenuator (btla) modulators and method of using same" on Wed, April 27, 2022

Filed a patent for "antibodies directed against t cell immunoglobulin and mucin protein 3 (tim-3)" on Thu, November 17, 2022